Incidence of skeletal morbidity rates over time in patients with multiple myeloma-related bone disease as reported in randomized trials employing bone-modifying agents

By Poon Michael   Zeng Liang   Zhang Liying   Hsiao Janey   Wong Erin   Lam Henry   Bedard Gillian   Chow Edward  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 1, 2013-01 ,pp. : 69-76

Future Medicine

Access to resources Recommend Favorite

Effect of interferon on the health‐related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan–prednisone to melphalan–prednisone + α‐interferon

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 324-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of interferon on the health‐related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan–prednisone to melphalan–prednisone + α‐interferon

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 324-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 1, 2015-01 ,pp. : 60-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients: a multicenter randomized controlled trial

By Stoutenbeek C.   Saene H.   Little R.   Whitehead A.  

Intensive Care Medicine, Vol. 33, Iss. 2, 2007-02 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite